ʻO ka PCR Fluorescence
-
Mycobacterium Tuberculosis Isoniazid Resistance Mutation
He kūpono kēia kit no ka ʻike qualitative o nā pae hoʻololi nui i nā laʻana sputum kanaka i hōʻiliʻili ʻia mai nā maʻi maʻi maʻi Tubercle bacillus e alakaʻi i ka mycobacterium tuberculosis isoniazid resistance: InhA promoter region -15C>T, -8T>A, -8T>C;ʻĀpana hoʻolaha AhpC -12C>T, -6G>A;homozygous mutation o KatG 315 codon 315G>A, 315G>C .
-
Staphylococcus Aureus a me Methicillin-Resistant Staphylococcus Aureus (MRSA/SA)
Hoʻohana ʻia kēia pahu no ka ʻike qualitative o staphylococcus aureus a me nā methicillin-resistant staphylococcus aureus nucleic acids i loko o nā laʻana sputum kanaka, nasal swab samples a me ka ʻili a me nā mea maʻi palupalu palupalu i loko o vitro.
-
Zika Virus
Hoʻohana ʻia kēia pahu e ʻike pono i ka Zika virus nucleic acid i loko o nā laʻana serum o nā maʻi i manaʻo ʻia he maʻi Zika virus in vitro.
-
Kāne Leukocyte Antigen B27 Nucleic Acid Detection Kit
Hoʻohana ʻia kēia pahu no ka ʻike qualitative o ka DNA i nā subtypes antigen leukocyte kanaka HLA-B*2702, HLA-B*2704 a me HLA-B*2705.
-
ʻO ka maʻi maʻi maʻi H5N1 Nucleic Acid Detection Kit
He mea kūpono kēia pahu no ka ʻike kūpono o ka maʻi maʻi H5N1 nucleic acid i loko o nā laʻana nasopharyngeal swab kanaka i loko o ka vitro.
-
15 Nā ʻano o ke kanaka Papillomavirus E6/E7 Gene mRNA
Kuhi ʻia kēia pahu i ka ʻike kūpono o 15 mau kiʻekiʻe kiʻekiʻe o ka papillomavirus kanaka (HPV) E6/E7 gene mRNA hōʻike pae i loko o nā cell exfoliated o ka pūpū wahine.
-
28 Nā ʻano o ka maʻi maʻi papilloma kanaka kiʻekiʻe (16/18 paʻi) ʻakika nucleic
He kūpono kēia pahu no ka ʻike in vitro qualitative o 28 mau ʻano o nā maʻi papilloma kanaka (HPV) (HPV6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53, 54, 56, 58, 59, 61, 66, 68, 73, 81, 82, 83) ʻakika nucleic i loko o ka mimi kāne / wahine a me nā pūpū exfoliated cervical wahine.Hiki ke paʻi ʻia ka HPV 16/18, ʻaʻole hiki ke paʻi piha ʻia nā ʻano i koe, e hāʻawi ana i mea kōkua no ka ʻike a me ka mālama ʻana i ka maʻi HPV.
-
28 Nā ʻano o ka HPV Nucleic Acid
Hoʻohana ʻia ka pahu no ka ʻike in vitro qualitative o 28 mau ʻano papillomaviruses kanaka (HPV6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53 , 54, 56, 58, 59, 61, 66, 68, 73, 81, 82, 83) waika nucleic i loko o ka mimi kāne / wahine a me nā pūpū exfoliated cervical wahine, akā ʻaʻole hiki ke paʻi piha ʻia ka maʻi.
-
Human Papillomavirus (28 ʻAno) Genotyping
Hoʻohana ʻia kēia pahu no ka ʻike qualitative a me ka genotyping o ka waikawa nucleic o 28 mau ʻano o ka papillomavirus kanaka (HPV6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52 , 53, 54, 56, 58, 59, 61, 66, 68, 73, 81, 82, 83) i loko o ka mimi kāne / wahine a me nā pūnaeho exfoliated cervical cervical, e hāʻawi ana i nā mea kōkua no ka ʻike a me ka mālama ʻana i ka maʻi HPV.
-
ʻO Enterococcus kū'ē iā Vancomycin a me Gene kū'ē i ka lāʻau
Hoʻohana ʻia kēia kit no ka ʻike qualitative o vancomycin-resistant enterococcus (VRE) a me kāna mau genes kūʻē i ka lāʻau VanA a me VanB i loko o ka sputum kanaka, koko, mimi a i ʻole nā kolone maʻemaʻe.
-
Kanaka Methylated NDRG4/SEPT9/SFRP2/BMP3/SDC2 Gene
Hoʻolālā ʻia ka pahu no ka ʻike in vitro qualitative o nā genes methylated NDRG4/SEPT9/SFRP2/BMP3/SDC2 i loko o nā pūnaewele exfoliated intestinal i loko o nā mea hoʻohālike o ke kanaka.
-
ʻO ke kanaka CYP2C9 a me VKORC1 Gene Polymorphism
Pili kēia kit i ka in vitro qualitative detection of polymorphism o CYP2C9*3 (rs1057910, 1075A>C) a me VKORC1 (rs9923231, -1639G>A) i loko o ka genomic DNA o ke kanaka holookoa koko samples.
